These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8338441)
1. Lipid apheresis by hemoperfusion: in vitro efficacy and ex vivo biocompatibility of a new low-density lipoprotein adsorber compatible with human whole blood. Bosch T; Schmidt B; Blumenstein M; Gurland HJ Artif Organs; 1993 Jul; 17(7):640-52. PubMed ID: 8338441 [TBL] [Abstract][Full Text] [Related]
2. LDL hemoperfusion--a new procedure for LDL apheresis: biocompatibility results from a first pilot study in hypercholesterolemic atherosclerosis patients. Bosch T; Schmidt B; Kleophas W; Otto V; Samtleben W Artif Organs; 1997 Oct; 21(10):1060-5. PubMed ID: 9335362 [TBL] [Abstract][Full Text] [Related]
3. LDL hemoperfusion--a new procedure for LDL apheresis: first clinical application of an LDL adsorber compatible with human whole blood. Bosch T; Schmidt B; Kleophas W; Gillen C; Otto V; Passlick-Deetjen J; Gurland HJ Artif Organs; 1997 Sep; 21(9):977-82. PubMed ID: 9288867 [TBL] [Abstract][Full Text] [Related]
4. DALI apheresis in hyperlipidemic patients: biocompatibility, efficacy, and selectivity of direct adsorption of lipoproteins from whole blood. Bosch T; Lennertz A; Schmidt B; Fink E; Keller C; Toepfer M; Dräger J; Samtleben W Artif Organs; 2000 Feb; 24(2):81-90. PubMed ID: 10718759 [TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein hemoperfusion using a modified polyacrylate adsorber: in vitro, ex vivo, and first clinical results. Bosch T Artif Organs; 1996 Apr; 20(4):344-5. PubMed ID: 9139622 [TBL] [Abstract][Full Text] [Related]
6. Ex vivo biocompatibility of avidin-agarose: a new device for direct adsorption of biotinylated antibodies from human whole blood. Bosch T; Lennertz A; Duhr C; Fink E; Samtleben W Artif Organs; 2000 Sep; 24(9):696-704. PubMed ID: 11012539 [TBL] [Abstract][Full Text] [Related]
7. Effect of low-dose citrate anticoagulation on the clinical safety and efficacy of direct adsorption of lipoproteins (DALI apheresis) in hypercholesterolemic patients: a prospective controlled clinical trial. Bosch T; Heinemann O; Duhr C; Wendler T; Keller C; Fink E; Kirschner T; Klebert S; Samtleben W Artif Organs; 2000 Oct; 24(10):790-6. PubMed ID: 11091168 [TBL] [Abstract][Full Text] [Related]
8. Heparin-free DALI LDL-apheresis in hyperlipidemic patients: efficacy, safety and biocompatibility. Wendler T; Lennertz A; Heinemann O; Duhr C; Samtleben W; Bosch T Int J Artif Organs; 2000 Oct; 23(10):710-7. PubMed ID: 11075902 [TBL] [Abstract][Full Text] [Related]
9. Direct adsorption of lipoproteins from whole blood by DALI apheresis: technique and effects. Bosch T Ther Apher; 2001 Aug; 5(4):239-43. PubMed ID: 11724507 [TBL] [Abstract][Full Text] [Related]
10. Low density lipoprotein hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis): clinical experience from a single center. Bosch T; Lennertz A; Kordes B; Samtleben W Ther Apher; 1999 Aug; 3(3):209-13. PubMed ID: 10427617 [TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of dextran sulfate cellulose beads for whole blood infusion low-density lipoprotein-hemoperfusion. Kobayashi A; Nakatani M; Furuyoshi S; Tani N Ther Apher; 2002 Oct; 6(5):365-71. PubMed ID: 12423531 [TBL] [Abstract][Full Text] [Related]
12. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating. Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934 [TBL] [Abstract][Full Text] [Related]
13. The impact of citrate concentration on adhesion of platelets and leukocytes to adsorbents in whole blood lipoprotein apheresis. Weiss R; Fischer MB; Weber V J Clin Apher; 2017 Dec; 32(6):375-383. PubMed ID: 27859540 [TBL] [Abstract][Full Text] [Related]
14. Modified DALI LDL-apheresis using trisodium citrate anticoagulation plus bicarbonate or lactate-buffered hemofiltration substitution fluids as primers. Bosch T; Wendler T; Maschke H Artif Organs; 2003 Jun; 27(6):555-64. PubMed ID: 12780510 [TBL] [Abstract][Full Text] [Related]
15. Practical aspects of direct adsorption of lipoproteins from whole blood by DALI LDL-apheresis. Bosch T Transfus Apher Sci; 2004 Oct; 31(2):83-8. PubMed ID: 15501411 [TBL] [Abstract][Full Text] [Related]
16. Selective removal of low-density lipoproteins from plasma by polyacrylate-coated Fractogel in vitro and in experimental extracorporeal perfusion. Thies K; Prigent SA; Heuck CC Artif Organs; 1988 Aug; 12(4):320-4. PubMed ID: 3178519 [TBL] [Abstract][Full Text] [Related]
17. C3a and C5a anaphylatoxins bind to heparin-based sorbent in low density lipoprotein apheresis: in vitro and in vivo investigations. Sinitsyn VV; Bokchubaev ET; Mamontova AG; Ovtrakht NV; Nasonov EL; Konovalov GA; Kukharchuk VV Artif Organs; 1992 Jun; 16(3):291-3. PubMed ID: 10078261 [TBL] [Abstract][Full Text] [Related]
18. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis. Bosch T; Lennertz A; Schenzle D; Dräger J; J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408 [TBL] [Abstract][Full Text] [Related]
19. DALI-the first human whole-blood low-density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical results. Dräger LJ; Julius U; Kraenzle K; Schaper J; Toepfer M; Zygan K; Otto V; Steinhagen-Thiessen E Eur J Clin Invest; 1998 Dec; 28(12):994-1002. PubMed ID: 9893010 [TBL] [Abstract][Full Text] [Related]
20. Direct adsorption of low-density lipoprotein by DALI-LDL-apheresis: results of a prospective long-term multicenter follow-up covering 12,291 sessions. Bosch T; Gahr S; Belschner U; Schaefer C; Lennertz A; Rammo J; Ther Apher Dial; 2006 Jun; 10(3):210-8. PubMed ID: 16817783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]